Stocktoria
PRECISION BIOSCIENCES INC DTIL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-03-28
PRECISION BIOSCIENCES INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -152.2% | -38.1% | -89.8% | -248.3% | -34.1% |
| Net margin | -133.4% | 10.4% | -125.8% | -444.8% | -26.5% |
| Return on assets | -29.6% | 5.3% | -38.4% | -46.9% | -14.5% |
| Return on equity | -49.6% | 12.7% | -325.1% | -184.7% | -33.6% |
| Debt / equity | — | — | — | 0.37× | 0.03× |
| Current ratio | 13.32 | 6.34 | 2.73 | 3.34 | 4.50 |
| Revenue growth | -50.1% | 41.0% | 94.1% | -78.3% | 375.7% |
Source: SEC EDGAR filings · CIK 0001357874 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.